Detalhe da pesquisa
1.
An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
J Immunol
; 200(4): 1513-1526, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29305435
2.
A novel biologic platform elicits profound T cell costimulatory activity and antitumor immunity in mice.
Cancer Immunol Immunother
; 67(4): 605-613, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29327109
3.
Therapeutic blockade of CD54 attenuates pulmonary barrier damage in T cell-induced acute lung injury.
Am J Physiol Lung Cell Mol Physiol
; 313(1): L177-L191, 2017 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28473322
4.
Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
J Immunol
; 195(12): 5816-26, 2015 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26561553
5.
Dog licks baby. Baby gets Pasteurella multocida meningitis.
Lancet
; 393(10186): e41, 2019 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-31226054
6.
Cytokines and metabolic factors regulate tumoricidal T-cell function during cancer immunotherapy.
Immunotherapy
; 9(1): 71-82, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28000531
7.
Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?
Expert Opin Biol Ther
; 16(5): 655-74, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26855028